Scotch Plains, NJ, United States of America

Mihirbaran Mandal

USPTO Granted Patents = 9 

 

 

Average Co-Inventor Count = 6.1

ph-index = 4

Forward Citations = 45(Granted Patents)


Location History:

  • New York, NY (US) (2009 - 2012)
  • Scotch Plains, NJ (US) (2011 - 2015)

Company Filing History:


Years Active: 2009-2015

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Mihirbaran Mandal: Innovator in Cancer Treatment

Introduction

Mihirbaran Mandal is a prominent inventor based in Scotch Plains, NJ (US), known for his significant contributions to cancer research. With a total of nine patents to his name, he has made remarkable strides in developing innovative treatments for various types of cancer.

Latest Patents

Mihirbaran Mandal's latest patents include groundbreaking work on Migrastatin analogs in the treatment of cancer. This invention provides a method for treating colon and/or ovarian cancer by administering a compound that effectively inhibits tumor metastasis. Another notable patent involves gamma secretase modulators, which are novel heterocyclic compounds that can be used in the treatment, prevention, and amelioration of diseases associated with the central nervous system.

Career Highlights

Throughout his career, Mihirbaran Mandal has worked with esteemed organizations such as the Sloan-Kettering Institute for Cancer Research and Merck Sharp & Dohme Corporation. His work in these institutions has allowed him to focus on developing innovative solutions to complex medical challenges.

Collaborations

Mihirbaran has collaborated with notable colleagues, including Zhaoning Zhu and Xiaoxiang Liu, to advance research in his field. Their combined expertise has contributed to the success of various projects and patents.

Conclusion

Mihirbaran Mandal's work exemplifies the spirit of innovation in cancer treatment. His contributions through patents and collaborations continue to pave the way for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…